EyeGene Inc. (KOSDAQ:185490)
2,880.00
+10.00 (0.35%)
At close: Sep 12, 2025
EyeGene Market Cap
EyeGene has a market cap or net worth of 75.14 billion as of September 16, 2025. Its market cap has decreased by -35.94% in one year.
Market Cap
75.14B
Enterprise Value
50.06B
Revenue
3.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,880.00
Market Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 75.14B, a decrease of -42.64%. That is a compound annual growth rate of -5.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 75.14B | 8.59% |
Dec 30, 2024 | 69.20B | -24.46% |
Dec 28, 2023 | 91.61B | -15.21% |
Dec 29, 2022 | 108.04B | -73.58% |
Dec 30, 2021 | 408.92B | 175.32% |
Dec 30, 2020 | 148.53B | 11.93% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Nov 16, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 499.67T |
SK hynix | 228.53T |
LG Energy Solution | 83.19T |
Samsung Biologics | 74.02T |
Hanwha Aerospace | 50.73T |
Hyundai Motor Company | 47.01T |
HD Hyundai Heavy Industries | 44.25T |
KB Financial Group | 43.55T |